Evolutionary Genomics, Inc. Proceeds from Stock Options Exercised
Evolutionary Genomics, Inc. reported Proceeds from Stock Options Exercised of $66.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2016-02-19.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2016-02-19
- Evolutionary Genomics, Inc. proceeds from stock options exercised for fiscal 2014 was $66.00K.
| Period end | Proceeds from Stock Options Exercised 12 month |
|---|---|
| 2014-12-31 | $66.00K 10-K · filed 2016-02-19 |